Kingswood Wealth Advisors LLC Cuts Stake in Baxter International Inc. (NYSE:BAX)

Kingswood Wealth Advisors LLC reduced its position in Baxter International Inc. (NYSE:BAX) by 9.3% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 7,416 shares of the medical instruments supplier’s stock after selling 764 shares during the quarter. Kingswood Wealth Advisors LLC’s holdings in Baxter International were worth $317,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of BAX. Headinvest LLC purchased a new position in Baxter International in the third quarter worth $25,000. Bruce G. Allen Investments LLC purchased a new position in Baxter International in the fourth quarter worth $36,000. Turtle Creek Wealth Advisors LLC purchased a new position in Baxter International in the fourth quarter worth $37,000. Hexagon Capital Partners LLC grew its holdings in Baxter International by 205.4% in the fourth quarter. Hexagon Capital Partners LLC now owns 953 shares of the medical instruments supplier’s stock worth $37,000 after purchasing an additional 641 shares during the last quarter. Finally, CKW Financial Group purchased a new position in Baxter International in the fourth quarter worth $43,000. 90.19% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities analysts have issued reports on BAX shares. Citigroup cut their price target on shares of Baxter International from $44.00 to $38.00 and set a “neutral” rating on the stock in a report on Wednesday, May 22nd. The Goldman Sachs Group started coverage on shares of Baxter International in a report on Thursday, May 30th. They set a “neutral” rating and a $36.00 price objective on the stock. Bank of America boosted their price objective on shares of Baxter International from $42.00 to $45.00 and gave the company a “neutral” rating in a report on Tuesday, March 5th. Finally, TD Cowen lowered shares of Baxter International from a “buy” rating to a “hold” rating and set a $40.00 price objective on the stock. in a report on Friday, May 10th. Nine equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $44.42.

Baxter International Trading Down 0.2 %

Shares of Baxter International stock opened at $33.45 on Friday. The firm has a 50-day simple moving average of $35.34 and a two-hundred day simple moving average of $38.68. The company has a market cap of $17.05 billion, a P/E ratio of 6.43, a price-to-earnings-growth ratio of 1.77 and a beta of 0.61. Baxter International Inc. has a fifty-two week low of $31.01 and a fifty-two week high of $50.21. The company has a debt-to-equity ratio of 1.35, a quick ratio of 1.01 and a current ratio of 1.48.

Baxter International (NYSE:BAX) last issued its quarterly earnings data on Thursday, May 2nd. The medical instruments supplier reported $0.65 earnings per share for the quarter, topping analysts’ consensus estimates of $0.61 by $0.04. The business had revenue of $3.59 billion during the quarter, compared to the consensus estimate of $3.55 billion. Baxter International had a net margin of 17.79% and a return on equity of 18.47%. The company’s revenue was down 1.6% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.59 earnings per share. As a group, equities analysts predict that Baxter International Inc. will post 2.91 earnings per share for the current fiscal year.

Baxter International Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, July 1st. Shareholders of record on Friday, May 31st will be given a $0.29 dividend. The ex-dividend date of this dividend is Friday, May 31st. This represents a $1.16 dividend on an annualized basis and a dividend yield of 3.47%. Baxter International’s dividend payout ratio (DPR) is currently 22.31%.

Baxter International Company Profile

Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories.